Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model.
NCT06828484 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-01-20
Summary
The goal of this study is to learn if a cat allergen extract known as Allergenic Extract Standardized Cat Hair Acetone Precipitated (AP Cat) can induce allergic rhinitis (AR) in a nasal allergen challenge model in cat-allergic people. The main questions this study aims to answer are:
1. Does AP Cat induce nasal symptoms of allergic rhinitis in cat-allergic participants when delivered intranasally?
2. Does AP Cat reduce elements in the blood and nose that are known to be associated with allergies?
Both allergic and non-allergic participants will be recruited into this study.
Allergic participants will:
* Be challenged with AP Cat via the Nasal Allergen Challenge (NAC), which involves administration of this allergen extract directly into the nose.
* Have nasal fluid and blood samples collected at various timepoints up to 24 hours after exposure to the allergen in the NAC.
* Visit the study site three separate times:
1. At screening (Visit 1), to determine eligibility to participate in this study
2. At the baseline NAC visit (Visit 2)
3. At the 24-hour post-NAC follow-up visit (Visit 3)
* Complete nasal symptom questionnaires.
* Complete a questionnaire about their regular exposure to cats.
Non-allergic participants will:
* Be challenged with AP Cat via the NAC, which involves administration of this allergen extract directly into the nose.
* Have nasal fluid and blood samples collected at various timepoints up to 24 hours after exposure to the allergen in the NAC.
* Visit the study site three separate times:
1. At screening (Visit 1), to determine eligibility to participate in this study
2. At the baseline NAC visit (Visit 2)
3. At the 24-hour post-NAC follow-up visit (Visit 3)
* Complete nasal symptom questionnaires.
This study will compare the nasal symptoms and allergic markers collected from the nasal fluid and blood samples between allergic and non-allergic participants at baseline and various timepoints post-NAC exposure.
Conditions
- Allergic Rhinitis
Interventions
- DRUG
-
Allergenic Extract Standardized Cat Hair Acetone-Precipitated (AP)
Cat-allergic and non-allergic participants will be exposed to AP Cat in the NAC.
Sponsors & Collaborators
-
Queen's University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-04
- Primary Completion
- 2026-01-08
- Completion
- 2026-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects
NCT03414801 ·Status: COMPLETED ·Phase: NA
-
A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms
NCT00637884 ·Status: COMPLETED ·Phase: PHASE4
-
Exposure Chamber Trial With Cat Immunotherapy
NCT00987909 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis
NCT00804687 ·Status: COMPLETED ·Phase: PHASE2
-
Nasal Allergen Challenge in Rhinitic Subjects
NCT01286129 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of AL-53817 Nasal Spray Solution
NCT01454505 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber
NCT00784732 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)
NCT00783224 ·Status: COMPLETED ·Phase: PHASE3
-
Repeat Dose Nasal Allergen Challenge
NCT01110837 ·Status: UNKNOWN ·Phase: NA
-
Study of BLU-808 in Allergic Rhinoconjunctivitis
NCT06922448 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
NCT03855228 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis
NCT05038202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo
NCT01076439 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure
NCT07219849 ·Status: RECRUITING ·Phase: PHASE2
-
Safety Study of Olopatadine Nasal Spray
NCT00578331 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a New Self-assessed, Home-based Symptom Score in Cat Allergic Patients
NCT02959073 ·Status: TERMINATED
-
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma
NCT00671268 ·Status: COMPLETED ·Phase: PHASE3
-
Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)
NCT00468312 ·Status: COMPLETED ·Phase: PHASE3
-
A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
NCT05692154 ·Status: COMPLETED ·Phase: PHASE3
-
The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population
NCT05093478 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)
NCT00779545 ·Status: COMPLETED ·Phase: PHASE2
-
Ability of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic Patients
NCT05656482 ·Status: UNKNOWN
-
Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
NCT00791102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
NCT02125253 ·Status: COMPLETED ·Phase: PHASE3
-
A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine
NCT01103050 ·Status: COMPLETED ·Phase: PHASE2